Screener
LivaNova LIVN R&D
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: LivaNova’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001639691-26-000090
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 273,670 | 238,988 | 517,419 | 455,242 |
| Operating expenses: | ||||
| Selling, general, and administrative | 158,128 | 137,780 | 301,696 | 266,926 |
| Research and development | 53,662 | 47,185 | 112,357 | 85,064 |
| Other operating expense | 12,396 | (160) | 12,411 | 452 |
| Operating income | 49,484 | 54,183 | 90,955 | 102,800 |
| SNIA environmental liability expense | — | (1,677) | — | (362,070) |
| Interest expense | (7,176) | (14,931) | (15,467) | (30,217) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is LivaNova's R&D?
- LivaNova (LIVN) reported R&D of $53.66M in Q2 2026.
- How has LivaNova's R&D changed year-over-year?
- LivaNova's R&D increased by 13.7% year-over-year, from $47.19M to $53.66M.
- What is the long-term trend for LivaNova's R&D?
- Over 4 years (2021 to 2025), LivaNova's R&D has grown at a 0.3% compound annual growth rate (CAGR), from $183.41M to $185.76M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about LivaNova's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude